EXPIRED
National Institutes of Health (NIH)
U24 Resource-Related Research Projects Cooperative Agreements
The overarching purpose of this initiative is to leverage the NHGRI-funded Genomic Data Science Analysis, Visualization and Informatics Lab-space (AnVIL) and other NIH cloud-based platforms, to enhance the diversity of individuals who have access to educational and research opportunities in computational genomics and data science (CGDS), including those from underrepresented groups. This initiative will focus on opportunities at the undergraduate and master’s degree level. The intent of this specific funding opportunity is to create a CGDS educational hub which will support activities to increase awareness of CGDS and cloud computing concepts, and address barriers to effective CGDS education. The Hub will coordinate with NIH cloud computing platforms to organize workshops, collect stakeholder input, disseminate materials, evaluate educational opportunities and provide logistical support.
June 27, 2022
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
July 27, 2022 | Not Applicable | Not Applicable | November 2022 | January 2023 | April 2023 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Not Applicable
It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide, except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts).
Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.
Applications that do not comply with these instructions may be delayed or not accepted for review.
Scientific Interests of Partnering NIH Institutes and Centers Are Delineated Below:
Specific Areas of Research Interest for ODSS:
ODSS will support research education and training activities that lead to enhanced data science access, knowledge, skills and proficiency, including individuals from groups that are underrepresented in the biomedical, clinical, behavioral and social sciences, in alignment with the Notice of NIH’s Interest in Diversity (NOT-OD-20-031). Activities are encouraged that help students develop foundational competencies in data science-relevant subjects, gain insight on the application of data science in biomedical research, or grow a biomedical data science community of peers and mentors.
Specific Areas of Research Interest for NIMHD:
NIMHD will support training activities that advance scientific understanding of the causes of health disparities and efforts to reduce health disparities and improve minority health. As part of its efforts to strengthen the national research capacity for minority health and health disparities research, NIMHD is committed to increasing the number of investigators from diverse backgrounds, including those from underrepresented groups (see, Notice of NIH’s Interest in Diversity, NOT-OD-20-031), pursuing biomedical research, particularly on diseases that disproportionately impact populations with health disparities https://www.nimhd.nih.gov/about/strategic-plan/. To this end, NIMHD is interested in supporting programs that increase educational opportunities for research projects that use approaches encompassing multiple domains of influence (e.g., biological, behavioral, sociocultural, environmental, physical environment, health system) and multiple levels of influence (e.g., individual, interpersonal, family, peer group, community, societal) to understand and address health disparities (see the NIMHD Research Framework, https://www.nimhd.nih.gov/about/overview/research-framework.html).
Specific Areas of Research Interest for All of Us:
The All of Us Research Program is part of an effort to advance individualized health care by enrolling one million or more participants to contribute their health data over many years. The comprehensiveness and availability of the cloud-based All of Us dataset directly supports an initiative to increase the pipeline of researchers from diverse backgrounds, including those who are underrepresented in the biomedical workforce. See, Notice of NIH’s Interest in Diversity, NOT-OD-20-031. Program efforts are creating capacity for an inclusive and diverse community of researchers using All of Us data to investigate questions that can lead to new discoveries that may one day prevent and treat disease for all communities.
All of Us is building a database to help transform the future of health research by equipping researchers nationwide with expansive health data from diverse populations. It is built in partnership with participants spanning different ages, races and ethnicities, and regions of the country. To date, All of Us has enrolled more than 372,000 participants who have completed the initial steps of the program, with nearly 50% from racial or ethnic minority populations as defined by the U.S. Census and approximately 80% from individuals who have been historically underrepresented in biomedical research. The All of Us Research Program defines populations that are underrepresented in biomedical research (UBR) as groups historically not well represented in biomedical research including clinical trials. Diversity is one of the core values of the All of Us Research Program. Participants are from different races, ethnicities, age groups, and regions of the country. They are also diverse in gender identity, sexual orientation, socioeconomic status, educational attainment, and health status.
Data collected includes physical measurements, lifestyle questions, electronic health records, and social determinants of health. All of Us provides custom tools and software to registered researchers to analyze participant data while keeping information secure.
The All of Us dataset is a unique opportunity for students and faculty that are studying computational genomics and data science (CGDS), to have access to one of the largest and most diverse datasets to advance training opportunities. The uniqueness of the data and diversity of the All of Us dataset can provide student trainees and their faculty mentors an unprecedented opportunity to begin to address complex questions in genomics while also investigating the intersectionality of how social determinants of health impact health inequities.
Available to registered researchers includes:
Using the All of Us dataset, CGDS students and faculty will be able to pair high powered genetics analysis with social determinants of health information to investigate complex, multidimensional, and intersecting influences on human health using one of the largest, most diverse, and well-curated datasets in the U.S.
Background
The National Institutes of Health (NIH) recognizes that scientists and students from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems (see NOT-OD-20-031 ). Benefits of a diverse scientific workforce include fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved populations participate in, and benefit from research, and enhancing public trust. Yet many institutions that enroll significant numbers of students from groups underrepresented in science are under-resourced and their faculty are supported by fewer NIH research grants. There is a pressing need to enhance educational and research capacity and opportunities for student research projects in biomedical science at such institutions.
Accordingly, the NIH continues to encourage institutions to diversify their student and faculty populations and to enhance the participation of individuals from diverse groups, including racial and ethnic groups nationally underrepresented in biomedical, clinical, behavioral, and social sciences research, those from disadvantaged backgrounds, and individuals with disabilities (see NOT-OD-20-031). Although the NIH currently provides multiple opportunities to develop research careers and improve participation for individuals from groups with lower representation in the biomedical and behavioral sciences, reports from the National Science Foundation (NSF) and others, provide strong evidence that diversity remains an ongoing challenge that must be addressed at every level of the educational pipeline.
As a leading authority in the field of genomics, NHGRI’s Strategic Vision is to be at the Forefront of Genomics by accelerating scientific and medical breakthroughs that improve human health and well-being. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society. This requires expertise in the foundational sciences relevant to genomics - biomedical, physical, mathematical, and computer and engineering sciences, biostatistics, epidemiology, bioinformatics, bioethics, social and behavioral sciences, law, and the humanities. Thus, research education in these areas will allow those who participate in NHGRI-supported research activities to be well positioned to contribute to biomedical research in the future. The Strategic Vision also highlights championing a diverse workforce as one of the guiding principles and values for genomics. As detailed in NHGRI’s 2021 Building a Diverse Genomics Workforce: An NHGRI Action Agenda , a major implementation goal for achieving that vision is to develop and support educational programs and networks that connect undergraduate and graduate education to careers in genomics. This includes ensuring that institutions that have a mission to serve groups that are currently underrepresented in the genomics enterprise are aware of and tightly connected to these networks.
Concurrently, the Strategic Vision highlights the importance of computational genomics and data science (CGDS) in sustaining and improving a robust foundation for genomics. CGDS is the cross-cutting area where statistics and computer science are used to understand, analyze, and interpret information from genome sequences. Genomics is inherently a big data field, and appropriate skills in data science and data stewardship are now prerequisites for becoming a genomics researcher. Therefore, the next generation of genomic scientists needs to be sufficiently trained in data science. However, not all undergraduate and master’s level students who are interested in genomics have access to the infrastructure and specialized education needed to obtain those skills.
In recent years, cloud computing technology has revolutionized CGDS, by democratizing access to genomics data sets, tools, and computing resources, and by enabling efficient genomic data sharing and collaboration. In contrast to traditional, locally provisioned, on-premises computing, cloud computing provides access to on-demand, scalable computing and storage resources with a variety of payment models, most of which scale with usage. Most cloud service providers also offer software services such as database management systems and/or machine learning toolboxes, etc. Cloud platforms also provide an opportunity to collocate data and computing resources in the same cloud for high-speed connection between the data and the computers.
Both NIH-supported and non-NIH supported researchers can access large scale genomics datasets through cloud-based platforms such as the NHGRI AnVIL, NHLBI BioData Catalyst, the All of Us Research Hub and the NCI Cancer Research Data Commons. NIH’s Office of Data Science Strategy (ODSS), as part of its mission to implement the NIH Strategic Plan for Data Science, has been a key leader of NIH’s cloud computing implementation through the NIH Science and Technology Research Infrastructure for Discovery, Experimentation, and Sustainability (STRIDES) program.
Purpose and Objectives
The overarching goal of this FOA is to increase availability and access to educational and research opportunities in cloud-based CGDS for undergraduate and masters degree students enrolled in institutions currently under-represented in CGDS. For this initiative, such institutions are hereafter termed Target Institutions , and are defined as those that have a mission to serve groups that are currently underrepresented in computational genomics and data science. Examples of Target Institutions include, but are not limited to, Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions (HSIs), Tribal Colleges and Universities (TCUs) and women’s colleges. By focusing on early career stages (undergraduate and master’s degree), this funding opportunity will enable students at such institutions to obtain a more robust foundation in CGDS and facilitate the development of a diverse data science and genomics workforce. Students and faculty intended to be engaged through this initiative include not only those who are part of biology or computer science departments, but other associated STEM disciplines as well (e.g., mathematics, statistics/biostatistics, and bioengineering.
The intent of the current FOA is to create a CGDS educational hub (hereafter referred to as the Hub ) which will support activities to increase awareness of CGDS and cloud computing services provided by the NHGRI-funded AnVIL and other NIH cloud-based platforms among such groups, and address barriers to effective CGDS education. A companion FOA will be released in FY24 to support the development of cloud-based CGDS instructional materials by faculty at Target Institutions.
This goal will be achieved through four complementary activities conducted by the Hub:
As a complement to classroom and cloud-based CGDS instructional content, the Hub should also support opportunities for students at Target Institutions to conduct hands-on genomic research projects . Specifically, in the fourth and fifth years of the five-year project period for this FOA (FY26 and FY27), the Hub will also be expected to administer a competitive opportunity for faculty at Target Institutions to receive support for hands-on student research projects in CGDS.
Resource Sharing
NHGRI expects that all educational or outreach materials, including curricula and syllabi, developed by the Hub will be made available as soon as they are ready under a CC BY 4 Creative Commons license, which will permit the public to use the materials without substantive restrictions (https://creativecommons.org/licenses/by/4.0/). NHGRI also expects that the availability of these materials to the broader CGDS education community will be communicated broadly and actively.
Licensing for software developed through this FOA will be expected to follow the least restrictive option from among existing licensing standards. The materials should be provided in easily shareable formats that are widely available at no cost. The non-Federal entity may copyright any work that is subject to copyright and was developed, or for which ownership was acquired, under a Federal award. The HHS awarding agency reserves a royalty-free, nonexclusive and irrevocable right to reproduce, publish, or otherwise use the work for Federal purposes, and to authorize others to do so.
All resources and tools developed by the Hub will be designed as non-proprietary and open source employing user interfaces that will allow the upload and download of resources. In addition, all resources and tools should be portable and easily transferred to other institutions as needed.
Annual Programmatic Meetings
The Hub will be expected to organize annual in-person/virtual hybrid meetings for members of the Hub, representatives of participating NIH cloud platforms and NIH program staff, and faculty at Target Institutions engaged in the Hub’s activities, including those supported by the companion FOA. These meetings will focus on sharing best practices and lessons learned among the sites, and on how to disseminate the curricula and teaching aids developed through this initiative with institutions beyond the immediate awardees. Additionally, at these annual meetings, the Hub will report progress, seek new research directions and ideas, and update NHGRI on issues of need.
Project Management
The leadership and management structure of the Hub should be commensurate to the complexity of the project. The project management structure should ensure the efficient planning, initiation, implementation, and timely completion of all activities as well as day-to-day oversight of the activities. Specific timelines and milestones should be developed and updated as needed, in collaboration with program staff from NHGRI and NIH partner Institutes, Centers and Offices (ICOs) for this FOA and the External Consultants Committee (see below). Metrics to assess the utilization of the resource and its impact on CGDS education in Target Institutions should also be developed. The project management should involve frequent interactions and communications with NHGRI staff, including hosting site visits, and preparing additional reports as requested by NHGRI staff.
Scientific Experts Group (SEG):
The PD/PI should develop plans for a Scientific Experts Group (SEG) to consult on the progress and priorities of the Hub. The SEG should encourage continuous improvements as methods, data, and needs change with time. A strong emphasis on operating in a cost-effective manner should be established. Applicants should describe how they would appoint and use the SEG, and how they plan to organize SEG meetings. Applicants should describe previous experiences with consultatory panels, how advice was incorporated into a project, and how the advice contributed to a project’s outcome. The SEG members should have expertise in a broad range of topics that are relevant to scientific workforce development, workforce diversity, CGDS education and research and ethical, legal, and social implications (ELSI) research.The SEG will meet, at a minimum, semi-annually (one conference call and one in-person meeting per year). Following each meeting, the SEG will submit their input to the PD/PI and NHGRI.
New applications should not name proposed SEG members or recruit members to serve on the SEG prior to the peer review of the application. However, they should describe the expertise to be included on the SEG.
Informational Webinar
NIH staff intend to hold a pre-application Informational Webinar for all interested prospective applicants to this funding opportunity. Webinar date and other details will be posted on https://www.genome.gov/event-calendar. NHGRI staff will be available to answer questions related to this FOA. Additional resources, including Frequently Asked Questions, will be posted on the website. Investigators planning to submit an application in response to this FOA are encouraged to contact and discuss their proposed research aims with the scientific contact listed in Section VII in advance of the application receipt date.
Responsiveness Criteria:
Applications nonresponsive to the goals and objectives of this FOA will not be reviewed, e.g.:
See Section VIII. Other Information for award authorities and regulations.
Cooperative Agreement: A support mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this FOA.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
Not Allowed: Only accepting applications that do not propose clinical trials.
NHGRI and partner components intend to commit a maximum of $1.5 million per year in total costs between FY23-FY25 to fund one Hub award, with an additional $300K Total costs per year for FY26 and FY27 for hands-on student research projects.
Application budgets may not exceed $1.5 million total costs per year for FY23-FY25, may not exceed $1.8 million total costs per year for FY26 and FY27, and must reflect the actual needs of the proposed project.
The scope of the proposed project should determine the project period. The maximum period is five years.
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA.
1. Eligible Applicants
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Local Governments
Federal Governments
Other
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Applicant organizations
Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Program Directors/Principal Investigators (PD(s)/PI(s))
All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. See, Notice of NIH’s Interest in Diversity, NOT-OD-20-031. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
2. Cost Sharing
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
3. Additional Information on Eligibility
Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct.
The NIH will not accept duplicate or highly overlapping applications under review at the same time, per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:
1. Requesting an Application Package
The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.
2. Content and Form of Application Submission
It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.Letter of Intent
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent by 11:59 PM, EST on June 27, 2022 to:
Shurjo K. Sen, Ph.D.
Telephone: 301-827-7028
Email: [email protected]
Page Limitations
All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.
Instructions for Application Submission
The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.
SF424(R&R) Cover
All instructions in the SF424 (R&R) Application Guide must be followed.
SF424(R&R) Project/Performance Site Locations
All instructions in the SF424 (R&R) Application Guide must be followed.
SF424(R&R) Other Project Information
All instructions in the SF424 (R&R) Application Guide must be followed.
SF424(R&R) Senior/Key Person Profile
All instructions in the SF424 (R&R) Application Guide must be followed.
The PD(s)/PI(s) should have appropriate experience and training in genomics, data science, community engagement with minority-serving institutions, educational content devekopment and cloud computing to be succesful leaders of the Hub. Early Stage Investigators or those in the early stages of independent careers listed as Senior Key Persons will be expected to have appropriate experience and training. Established investigators will be expected to have demonstrated an ongoing record of accomplishments that have advanced the above fields. If the project is collaborative or multi-PD/PI, the investigators should have complementary and integrated expertise.
Specifically, the PD(s)/PI(s) should have a track record in (a) culturally aware career development and mentoring (b) curriculum and/or educational materials/activities development, assessment, and dissemination (c) incorporation of ethical considerations in skills and workforce development activities, leading to an ongoing record of accomplishments in CGDS education. They should have a track record of successfully engaging Target Institutions for undergraduate and master’s degree level educational initiatives, and significant experience with coordinating collaborative educational initiatives, including experience overseeing selection and management of subawards.
R&R Budget
All instructions in the SF424 (R&R) Application Guide must be followed.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional considerations:
R&R Subaward Budget
All instructions in the SF424 (R&R) Application Guide must be followed.
PHS 398 Cover Page Supplement
All instructions in the SF424 (R&R) Application Guide must be followed.
PHS 398 Research Plan
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:
.
Research Strategy:In the Research Strategy, applicants should propose plans, approaches, and potential alternative strategies for carrying out the activities of the Hub as described in the Purpose and Objectives section above. The Research Strategy should consist of the following sections. Details about what should be discussed in each section are described below.
1. Overview of the Hub
2. Plans and Approaches to Create a Community of Target Institutions Interested in CGDS Education and Cloud Computing, and Identify Challenges Currently Faced by These Institutions
3. Plans and Approaches to Facilitate CGDS and Cloud Computing Educational Initiatives at Target Institutions
The scope of the Hub does not include a mandate to independently create classroom lectures or online labs in CGDS. Those activities are envisioned as a partnership between the Hub and the Target Institutions. The primary roles of the Hub are intended to be focused either at the foundational stage of increasing awareness of and familiarity with CGDS and cloud computing concepts, assisting and facilitating faculty at Target Institutions to create educational material in these areas, and finally to adapt such content to be stored, taught and shared using NIH-funded cloud platforms. In this context, applicants should:
Describe plans for researchers to access the resource data or materials, including plans to make available the entire resource and data schema
Describe plans to implement Findable, Accessible, Interoperable and Reusable (FAIR) guidelines for Hub activities
The Hub is not intended to support development of educational content that focuses on genomics or genetics without including a strong computational or analytical focus. Support may be provided for including basic genomics concepts in courses that are otherwise intended to teach CGDS topics.
4. Plans and Approaches to Create a Cloud-Hosted Platform for CGDS Educational Resources
Applicants should:
5. Strategies for Administering Opportunity Funds for Student Research Projects at Target Institutions
Applicants should:
6. Timeline
Leadership and project management plan: Applicants should clearly describe the division of responsibilities for the whole project. The plan should also describe how the PD(s)/PI(s) will manage the proposed Hub, coordinate the day-to-day activities and support achievement of the proposed goals and milestones, and plans for conflicts resolutions both internally at the Hub as well as with external collaborators at Target Institutions.
Plan for Instruction in the Responsible Conduct of Research: All applications must include a plan to fulfill NIH requirements for instruction in the Responsible Conduct of Research (RCR). The plan must address the five, required instructional components outlined in the NIH policy: 1) Format - the required format of instruction, i.e., face-to-face lectures, coursework, and/or real-time discussion groups (a plan with only on-line instruction is not acceptable); 2) Subject Matter - the breadth of subject matter, e.g., conflict of interest, authorship, data management, human subjects and animal use, laboratory safety, research misconduct, research ethics; 3) Faculty Participation - the role of the program faculty in the instruction; 4) Duration of Instruction - the number of contact hours of instruction, taking into consideration the duration of the program; and 5) Frequency of Instruction instruction must occur during each career stage and at least once every four years. See also NOT-OD-10-019. The plan should be appropriate and reasonable for the nature and duration of the proposed program.
Applications lacking a plan for instruction in Responsible Conduct of Research will not be reviewed.
Evaluation Plan: Applications must include a plan for evaluating the activities supported by the award. The application must specify baseline metrics (e.g., numbers, educational levels, and demographic characteristics of faculty and students at Target Institutions engaged by the Hub in CGDS educational activities), as well as measures to gauge the short or long-term success of the award in achieving its objectives. Wherever appropriate, applicants are encouraged to obtain feedback from participants to help identify weaknesses and to provide suggestions for improvements.
Applications lacking an Evaluation Plan will not be reviewed.
Dissemination Plan: A specific plan must be provided to disseminate nationally any findings resulting from or materials developed under the auspices of the Hub, e.g., sharing course curricula and related materials via web postings, presentations at scientific meetings, workshops
.
Other elements: Applicants are encouraged to include in the application additional topics or features that may improve the quality and effectiveness of the services provided by the Hub resource.
Letters of Support: Applicants should include letters of support from any person or group that is providing the proposed project with resources, such as materials, data, or software. Applicants should include letters only from those offering specific resources and collaborations, rather than many letters of general support, to avoid unnecessarily limiting the pool of non-conflicted reviewers.
Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide.
The following modifications also apply:
All resources and tools developed by the Hub will be portable and easily transferred if needed.
All applications, regardless of the amount of direct costs requested for any one year, must address a plan for sharing educational tools and other resources produced by the Hub. The plans may include policies for access and sharing; including provisions for appropriate protection of privacy, confidentiality, security, intellectual property, or other rights or requirements.
For Educational Tools: In the body of the text, the section should begin with a heading indicating "Tool Sharing Plan". Tool Sharing Plans should provide details for the tool components or modules, tool parameters and associated datasets. The plan should include the minimum requirements for tool documentation, tool building, tool validation and tool reproducibility. Applicants are also expected to include plans to link proposed tools with other relevant tools. Any software associated with proposed tools are expected to also be addressed in the Software Sharing Plan (below).
For Software: In the body of the text, the section should begin with a heading indicating "Software Sharing Plan". There is no prescribed single license for software produced through grants responding to this announcement. However,
Appendix:
Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
Plan for Enhancing Diverse Perspectives (PEDP)
Application to this FOA requires a Plan for Enhancing Diverse Perspectives (PEDP). Applications submitted without a PEDP will be considered incomplete and will be withdrawn prior to peer review. A PEDP is a summary of strategies to advance the scientific and technical merit of the proposed project through inclusivity. Broadly, diverse perspectives refer to the people who do the research, the places where research is done, as well as the people who participate in the research as part of the study population. The PEDP is submitted as a 2-page Other Attachment . Within the two pages, applicants should include a timeline and milestones for relevant components that will be considered as part of the review. Within the Research Strategy, applicants should align their description with the PEDP strategies and milestones and are encouraged to refer to information included in the PEDP attachment. In the 2-page PEDP summary, applicants are expected to show how enhancing diverse perspectives is supported throughout the application and how this strengthens the scientific and technical merit of the project (in terms of significance, investigator(s), innovation, approach, and environment), as appropriate. It is anticipated thatevery PEDP will be unique and will depend on the content and structure of the scientific aims, the required expertise, the environment, and the performance site(s).
Examples of items that advancing diverse perspectives in research and may be part of the PEDP can include, but are not limited to:
PHS Human Subjects and Clinical Trials Information
When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:
If you answered Yes to the question Are Human Subjects Involved? on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.
Study Record: PHS Human Subjects and Clinical Trials Information
All instructions in the SF424 (R&R) Application Guide must be followed.
Delayed Onset Study
Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start).All instructions in the SF424 (R&R) Application Guide must be followed.
PHS Assignment Request Form
All instructions in the SF424 (R&R) Application Guide must be followed.
3. Unique Entity Identifier and System for Award Management (SAM)
See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov.
4. Submission Dates and Times
Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
5. Intergovernmental Review (E.O. 12372)
This initiative is not subject to intergovernmental review.
6. Funding Restrictions
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
7. Other Submission Requirements and Information
Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.
Important reminders:
All PD(s)/PI(s) must include their eRA Commons ID in the Credential fieldof the Senior/Key Person Profile form. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this FOA for information on registration requirements.
The applicant organization must ensure that the unique entity identifier (DUNS number or UEI as required) provided on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.
See more tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review and responsiveness by components of participating organizations, NIH. Applications that are incomplete, non-compliant and/or nonresponsive will not be reviewed.
In order to expedite review, applicants are requested to notify the NHGRI Referral Office by email at [email protected] when the application has been submitted. Please include the FOA number and title, PD(s)/PI(s) name(s), and title of the application.
Requests of $500,000 or more for direct costs in any year
Not applicable.
Post Submission Materials
Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy.
1. Criteria
Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.
Overall Impact
Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.
Does the project address an important problem or a critical barrier to progress in the field? Is the prior research that serves as the key support for the proposed project rigorous? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Specific to this FOA: Is the proposed resource valuable for the broad genomics research community?
Does the proposed resource address the needs of the community to have access to adequate resources for teaching CGDS using cloud computing as an educational tool? Is the scope of activities proposed for the resource appropriate to meet those needs? Will successful completion of the aims bring unique advantages or capabilities to the CGDS education community?
To what extent do the efforts described in the Plan for Enhancing Diverse Perspectives further the significance of the Hub?
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or those in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Specific to this FOA: ?
Do the investigators have a track record in (a) culturally aware career development and mentoring (b) curriculum and/or educational materials/activities development, assessment, and dissemination (c) incorporation of ethical considerations in skills and workforce development activities? Do they have appropriate experience and training, and have they demonstrated experience and an ongoing record of accomplishments in CGDS education? Do the investigators have a track record of successfully engaging Target Institutions for undergraduate and master’s degree level educational initiatives? Do the investigators demonstrate significant experience with coordinating collaborative educational initiatives? Does the proposed personnel include expertise in human subjects research?
Does the applicant have experience overseeing selection and management of subawards, if needed?
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
Specific to this FOA:
Does this application propose novel technical approaches and administrative solutions to support the needs of CGDS education at Target Institutions? Are the concepts and strategies novel and applicable in a broad sense? Are the plans for leveraging cloud computing as an educational tool innovative and adequate? Does the application propose innovative strategies for engaging and building trust with faculty at Target Institutions?
Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators included plans to address weaknesses in the rigor of prior research that serves as the key support for the proposed project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?
If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from research risks, and 2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of individuals of all ages (including children and older adults), justified in terms of the scientific goals and research strategy proposed?
Specific to this FOA:
Are the methods to produce the resource efficient and cost-effective? If the size of the resource is likely to increase over time, will the proposed methods work at increased scale to allow the applicants to meet the goals in an efficient and cost-effective way?
Are the approaches for identifying challenges faced by Target Institutions in teaching cloud computing and CGDS concepts adequate? Are the proposed solutions for working with appropriate stakeholders and collaborators to develop and test strategies to address these challenges adequate? Is an well-designed evaluation plan included for testing the effectiveness of these strategies? Does the applicant propose a plan for organizing well-structured workshops and hands-on learning sessions on cloud computing and CGDS concepts for students and faculty at Target Institutions and recruiting participants to these events? Are the proposed cloud cost control and tracking methods adequate? Is the proposed user billing model appropriate?
Does the application include strategies for assisting faculty at Target Institutions in developing CGDS instructional content that leverages the computing resources and datasets available through the NHGRI AnVIL and other NIH cloud platforms? Does the applicant include strategies for disseminating these curricula and associated materials to the broader educational community? Does the application include train-the-trainer content for faculty members at Target Institutions to teach cloud-based CGDS courses?
Does the proposed cloud-based infrastructure and software platform meet the goal to facilitate CGDS education at Target Institutions? Is the proposed approach for ingesting third-party educational content and adapting it for use and sharing through cloud environments adequate? Are plans for addressing interoperability among different cloud platforms that may be used by the Hub adequate?
Are the proposed plans for providing educational outreach and soliciting users feedback from the research community adequate?
Are the plans for collaborative activities and interoperability approaches among different cloud platforms for use as educational tools adequate?
Are the proposed initial datasets to be hosted and made available by the resource of broad utility to the genomic research community and of appropriate size and quality for developing educational content?
Are the plans for ensuring and maintaining data access, data security, including audits of the data security processes, adequate? Are the proposed plans for user authentication and authorization appropriate?
Should funding for this Hub come to an end, is a plan for the transfer of Hub resources (i.e., online portal, databases, software and other code) to NHGRI or another entity clearly described, reasonable and appropriate?
How adequate is the proposed Resource Sharing Plan? Are well-developed proposals for sharing educational tools and software developed by the Hub included?
Are the timeline and milestones associated with the Plan for Enhancing Diverse Perspectives well-developed and feasible?
Are the planned efforts for the PD/PI appropriate and sufficient for the work proposed? For MPI applications, is the aggregate effort for the MPIs appropriate and sufficient for the work proposed
How adequate is the proposed governance structure, including its timelines and milestones? Is the leadership structure appropriate for this resource project, including the level of effort of key personnel? Is the project schedule reasonable and well thought out? Is the plan for interacting and soliciting input from the SEG appropriate
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
Specific to this FOA:
Will the range of departments and/or institutions involved enhance the diversification of the team in terms of the backgrounds, and expertise and skills of the researchers?
To what extent will features of the environment described in the Plan for Enhancing Diverse Perspectives (e.g., collaborative arrangements, geographic diversity, institutional support) contribute to the success of the Hub?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.
For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
Not applicable
Not applicable
Not applicable
How is the balance of the proposed activities responsive to the needs and opportunities of the potential user communities?
How adequate are the plans to collect, update, maintain, and publicly release the data and tools developed? How adequate are the plans to ensure that curation is accurate and that error propagation is minimized?
How adequate are the plans for researchers to access the resource data or materials, including plans to make available the entire resource and data schema? How well does the resource plan implement the Findable, Accessible, Interoperable and Reusable (FAIR) guidelines?
How adequate are the plans for providing educational programs to the research community on how to use the resource, if appropriate? Are the proposed metrics to assess the utilization of the Hub and its impact on the genomic research community adequate?
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.
Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: (1) Data Sharing Plan; (2) Sharing Model Organisms; and (3) Genomic Data Sharing Plan (GDS).
For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
2. Review and Selection Process
2. Review and Selection Process
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.
As part of the scientific peer review, all applications will receive a written critique.
Applications may undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.
Appeals of initial peer review will not be accepted for applications submitted in response to this FOA.
3. Anticipated Announcement and Award Dates
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
1. Award Notices
If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the recipient's business official.
Recipients must comply with any funding restrictions described in Section IV.6. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website. This includes any recent legislation and policy applicable to awards that is highlighted on this website.
Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.
2. Administrative and National Policy Requirements
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities, including of note, but not limited to:
If a recipient is successful and receives a Notice of Award, in accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.
Should the applicant organization successfully compete for an award, recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights laws that prohibit discrimination on the basis of race, color, national origin, disability, age and, in some circumstances, religion, conscience, and sex (including gender identity , sexual orientation, and pregnancy). This includes ensuring programs are accessible to persons with limited English proficiency and persons with disabilities. The HHS Office for Civil Rights provides guidance on complying with civil rights laws enforced by HHS. Please see https://www.hhs.gov/civil-rights/for-providers/provider-obligations/index.html and https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html
HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA.
Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call 1-800-368-1019 or TDD 1-800-537-7697.
In accordance with the statutory provisions contained in Section 872 of the Duncan Hunter National Defense Authorization Act of Fiscal Year 2009 (Public Law 110-417), NIH awards will be subject to the Federal Awardee Performance and Integrity Information System (FAPIIS) requirements. FAPIIS requires Federal award making officials to review and consider information about an applicant in the designated integrity and performance system (currently FAPIIS) prior to making an award. An applicant, at its option, may review information in the designated integrity and performance systems accessible through FAPIIS and comment on any information about itself that a Federal agency previously entered and is currently in FAPIIS. The Federal awarding agency will consider any comments by the applicant, in addition to other information in FAPIIS, in making a judgement about the applicant’s integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 45 CFR Part 75.205 and 2 CFR Part 200.206 Federal awarding agency review of risk posed by applicants. This provision will apply to all NIH grants and cooperative agreements except fellowships.
The following special terms of award are in addition to, and not in lieu of, otherwise applicable U.S. Office of Management and Budget (OMB) administrative guidelines, U.S. Department of Health and Human Services (DHHS) grant administration regulations at 45 CFR Part 75, 2 CFR Part 200, and other HHS, PHS, and NIH grant administration policies.
The administrative and funding instrument used for this program will be the cooperative agreement, an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial NIH programmatic involvement with the recipients is anticipated during the performance of the activities. Under the cooperative agreement, the NIH purpose is to support and stimulate the recipients' activities by involvement in and otherwise working jointly with the award recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities. Consistent with this concept, the dominant role and prime responsibility resides with the recipients for the project, although specific tasks and activities may be shared among the awardees and the NIH as defined below.
The PD(s)/PI(s) will have the primary responsibility for:
Data/software ownership and transition to another grantee:
The Hub will host genomic data and educational content generated by either itself, by faculty at Target Institutions, or by the NHGRI AnVIL or other NIH cloud platforms, and the Hub recipient is responsible for the proper stewardship and security of all data. A fundamental objective of this cooperative agreement is to ensure that the valuable data and software resources provided by the Hub remain available without interruption to the research community if recipient withdraws or otherwise can no longer manage the resource or the award is terminated by the NIH.
Consistent with 45 C.F.R. 75.322, the recipient will own the data generated and software developed by the recipient, and it will be able to continue to use these data and software upon expiration or termination of the award. NIH will have unrestricted cost-free access and use of the data and software generated by the recipient, including the right to transfer said data and/or software to other NIH-funded and/or managed resource projects, at the NIH's sole reasonable discretion upon termination or expiration of this cooperative agreement.
Ownership of the data, educational content and software hosted by the Hub remain with the data and software providers. The Hub has no possessor rights of the data and software provided or generated by its users, who will retain ownership and control of their own resources.
Open Source Technology: Capabilities and software built as part of the Hub must be delivered under an open source model. Organizations may propose to use proprietary platforms, so long as the requirements for data transparency and interoperability are maintained.
NIH staff have substantial programmatic involvement that is above and beyond the normal stewardship role in awards, as described below:
The Project Scientist/Scientific Officer (PS/SO) at NHGRI is a dual role held by a NHGRI Program Director (PD). In the Project Scientist role, the Program Director will have substantial scientific and programmatic involvement during the conduct of this activity through technical assistance, advice, and coordination. In the Scientific Officer role, the Program Director will be responsible for the normal scientific and programmatic stewardship of the award and manages concerns about bias as it affects the project. The role of NHGRI PS/SO will be to facilitate and not to direct the activities. The PS/SO will be named in the Notice of Award.
The PS/SO will have the following substantial involvement:
Areas of Joint Responsibility include:
Due to the complexity regarding the infrastructure and services provided by the Hub, a close, and collaborative, interaction among PIs/PDs, and staff at NIH will be required. An example of such interaction is promoting the availability of the data and related resources developed in the course of this service to the scientific community at large. Another area of joint responsibility is that the NIH staff and the PIs/PDs will work with and provide information to the SEG. Other areas of joint responsibility include:
Publications:
The PIs/PDs are encouraged to generate publications regarding the Hub infrastructure and services.
For datasets used by the Hub that have not been publicly released, the PIs/PDs will need to get approval in writing from the data owners before using the data.
Dispute Resolution:
Any disagreements that may arise in scientific or programmatic matters between award recipients and the NIH may be brought to Dispute Resolution. A Dispute Resolution Panel composed of three members will be convened, including a designee of the Hub SEG, one NIH designee, and a third designee with expertise in the relevant area who is chosen by the other two; in the case of NIH and Hub SEG cannot reach an agreement on the third member, the third member may be chosen by the individual recipient. This special dispute resolution procedure does not alter the recipient's right to appeal an adverse action that is otherwise appealable in accordance with PHS regulation 42 CFR Part 50, Subpart D and DHHS regulation 45 CFR Part 16.
3. Reporting
When multiple years are involved, recipients will be required to submit the Research Performance Progress Report (RPPR) annually and financial statements as required in the NIH Grants Policy Statement.
Programs that involve participants should report on education in the responsible conduct of research and complete a Trainee Diversity Report, in accordance with the RPPR Instruction Guide.
A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement. NIH FOAs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 45 CFR Part 75.301 and 2 CFR Part 200.301.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for recipients of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All recipients of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over the threshold. See the NIH Grants Policy Statement for additional information on this reporting requirement.
In accordance with the regulatory requirements provided at 45 CFR 75.113 and 2 CFR Part 200.113 and Appendix XII to 45 CFR Part 75 and 2 CFR Part 200, recipients that have currently active Federal grants, cooperative agreements, and procurement contracts from all Federal awarding agencies with a cumulative total value greater than $10,000,000 for any period of time during the period of performance of a Federal award, must report and maintain the currency of information reported in the System for Award Management (SAM) about civil, criminal, and administrative proceedings in connection with the award or performance of a Federal award that reached final disposition within the most recent five-year period. The recipient must also make semiannual disclosures regarding such proceedings. Proceedings information will be made publicly available in the designated integrity and performance system (currently FAPIIS). This is a statutory requirement under section 872 of Public Law 110-417, as amended (41 U.S.C. 2313). As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available. Full reporting requirements and procedures are found in Appendix XII to 45 CFR Part 75 and 2 CFR Part 200 Award Term and Condition for Recipient Integrity and Performance Matters.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)
Finding Help Online: http://grants.nih.gov/support/ (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)
General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: [email protected] (preferred method of contact)
Telephone: 301-480-7075
Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace)
Contact Center Telephone: 800-518-4726
Email: [email protected]
Shurjo K. Sen, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-7028
Email: [email protected]
Rudy Pozzatti, Ph.D.
National Human Genome Research Institute (NHGRI)
Phone: 301-402-8739
Email: [email protected]
Natalie Linear
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-0611
Email: [email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200.